(Q44620563)

4 December 2017

title

Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus (English)

1 reference

4 December 2017

0 references

Danica D Labudovic

1

1 reference

4 December 2017

Katerina N Toseska

series ordinal

2

1 reference

4 December 2017

Sonja B Alabakovska

series ordinal

3

1 reference

4 December 2017

Bojana B Todorova

series ordinal

4

1 reference

4 December 2017

publication date

1 October 2003

1 reference

4 December 2017

published in

Clinical Biochemistry

1 reference

4 December 2017

volume

36

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

545-551

1 reference

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Diabetes and cardiovascular risk factors: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

A structural assessment of the apo[a] protein of human lipoprotein[a]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Decrease of Lipoprotein(a) With Improved Glycemic Control in IDDM Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lipoprotein(a) levels in black and white children and adolescents with IDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lipoprotein(a) in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Peripheral atherosclerosis and serum lipoprotein(a) in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lipoprotein Lp(a) and the risk for myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

The role of lipoprotein(a) in the vascular complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Apo(a) isoforms predict risk for coronary heart disease. A study in six populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

Molecular genetics of lipoprotein (a): new pieces to the puzzle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2803%2900065-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9120(03)00065-1

1 reference

4 December 2017

1 reference